Very true that financial remuneration is almost always involved in the marketing of medical products by medical professionals. I also agree, the truth definitely is reflected in the sales and recurring revenue numbers - I don't doubt the existing iTrack customers will transition over to the Advance. I haven't compared the revenue per customer across the competition, if you have the numbers handy that would be very helpful.
EYE Price at posting:
25.5¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)